This site uses cookies in order to regularly improve the operation of the site. You declare that you agree herewith by using this website. Further information


About us

As a pharmaceutical company, we manufacture and scientifically research preparations for integrative cancer treatment. People are always in the focus of our business – either as patients, customers, partners or employees.

Our aim is to support medical professionals, patients and relatives and to improve their quality of life. We pursue a holistic approach by focusing not only on the disease but on each person as an individual.

Our preparations are based on the fundamental research of Ita Wegman and Rudolf Steiner. At Institute Hiscia, we have been committed to the ongoing research and development of anthroposophical medicines, their production and worldwide distribution for more than 70 years. We have the ambition to improve the possibilities of integrative cancer therapy and to complement conventional medicine in the best way possible.

We believe in close partnerships with our suppliers and customers and in sustainable growth. We reinvest any profit into research and projects that contribute to achieving our goals.

Thanks to decades of careful cultivation, our mistletoe plants thrive on mother trees in Switzerland, Germany and France. It is not only important to us to grow and process them locally and sustainably – we also work efficiently, flexibly and cost-consciously and offer healthy and modern workplaces to all our employees.

Hiscia Institute in Arlesheim, Switzerland

You are leaving the website of Iscador AG

You are leaving the website of Iscador AG and are going to the website of another provider. The contents published there as well as their designs have been created without the assistance of Iscador AG and are subject to the exclusive responsibility of the other provider. Iscador AG shall not assume any liability for the accuracy, completeness and actuality of this information and possible consequences from their use. You accept the aforementioned information by continuing on to the external page.